Comparison

Icotinib European Partner

Item no. TMO-T6153-1mg
Manufacturer TargetMol
CASRN 610798-31-7
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Conmana,BPI-2009H,BPI-2009
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
391.42
Description
Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.
Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||JAK/STAT signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close